3.7 millionStockhouse has update the AEZS shares outstanding to 3.7 million. That likely includes the warrants that were issued to AEZS holders immediately before the merger closed.
That's a C$28 million market cap at C$7.6.
$28 million market cap would be C$.36 per CZO before the merger.
H.C. Wainwright had a C$100 million market cap target for AEZS before the merger and that was set before a big rally in biotech.
C$100 million market cap with 3.7 million shares is C$27 per AEZS shares and that ignores the merger of equals potentially doubling the value and that H.C. Wainwright's target was set before a huge surge in biotech shares.